openPR Logo
Press release

Montelukast Sodium Global Market Overview, Driving Factors, Future Trends, Key Players and Growth Opportunities And Forecast By 2033 | Pfizer Inc., Sanofi Aventis SA, Hetero Labs Ltd., Cipla Inc., LGM Pharma LLC

Montelukast Sodium Market

Montelukast Sodium Market

"The new report published by The Business Research Company, titled ""Montelukast Sodium Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the montelukast sodium market size has grown strongly in recent years. It will grow from $3.52 billion in 2023 to $3.86 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The montelukast sodium market size is expected to see strong growth in the next few years. It will grow to $5.59 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16123&type=smp

Rising Prevalence Of Asthma Fuels Growth In The Montelukast Sodium Market
The increasing prevalence of asthma is expected to propel the growth of montelukast sodium market going forward. Asthma is a chronic respiratory disorder marked by inflammation and constriction of the airways, resulting in repeated bouts of wheezing, breathlessness, chest tightness, and coughing. The prevalence of asthma is increasing due to environmental pollution, allergen exposure, genetic predisposition, urbanization, changes in lifestyle, and respiratory infections. Montelukast sodium is used in asthma as a leukotriene receptor antagonist, helping to prevent and manage asthma symptoms by blocking the action of leukotrienes, which contribute to airway inflammation and constriction. For instance, in September 2022, according to the National Health Service, a UK-based government department, hospital admissions for children with asthma in England and Wales surged by 149% between 2021 and 2022. The number of children admitted with asthma symptoms rose to 19,506, compared to 7,850 during the 2020 to 2021 period. Therefore, the increasing prevalence of asthma is driving the growth of montelukast sodium market.

Introduction Of New Anti-Allergy Treatment Transforming The Montelukast Sodium Market
Major companies operating in the montelukast sodium market are developing new drugs such as fexofenadine hydrochloride and getting them approved to expand their product portfolios and address the evolving needs of patients with allergic conditions. Fexofinadine hydrochloride is a second-generation antihistamine medication approved by the FDA for treating allergy symptoms and hay fever in adults and children. For instance, in December 2021, Morepen Laboratories received approval from the US Food and Drug Administration (USFDA) to market its generic anti-allergy drug, Fexofinadine Hydrochloride, in the American market. Fexofinadine hydrochloride, a widely used second-generation antihistamine, is employed to treat allergy symptoms and hay fever. This approval signifies a significant milestone for Morepen Laboratories, strengthening its position in the anti-allergy market.

The montelukast sodium market covered in this report is segmented -
1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application : Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16123&type=discount

Major companies operating in the montelukast sodium market are Pfizer Inc., Merck & Co. Inc., Sanofi Aventis SA, Teva Pharmaceuticals USA Inc., Hetero Labs Ltd., Sun Pharma Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Intas Pharmaceuticals Ltd., Seqens Group, Sanyo Chemical Industries Ltd., Morepen Laboratories, Neuland Laboratories Ltd., Medopharm Private Ltd., BEC Chemicals Pvt. Ltd, Delmar Chemicals Inc., Kimia Biosciences Ltd., Ortin Laboratories Ltd., MSN Laboratories Pvt Ltd., Vamsi Labs Ltd., LGM Pharma LLC, HRV Global Life Sciences, Sigmak Lifesciences, Akums Lifesciences Ltd., Anwita Drugs & Chemicals Pvt Ltd

Contents of the report:
1. Executive Summary
2. Montelukast Sodium Market Report Structure
3. Montelukast Sodium Market Trends And Strategies
4. Montelukast Sodium Market - Macro Economic Scenario
5. Montelukast Sodium Market Size And Growth
…..
27. Montelukast Sodium Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/montelukast-sodium-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Montelukast Sodium Global Market Overview, Driving Factors, Future Trends, Key Players and Growth Opportunities And Forecast By 2033 | Pfizer Inc., Sanofi Aventis SA, Hetero Labs Ltd., Cipla Inc., LGM Pharma LLC here

News-ID: 3584744 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Montelukast

Montelukast Intermediate Market Pharmaceutical Ingredient Demand Growth
On April 11, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Montelukast Intermediate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Montelukast Market 2022-2027 Business Analysis by Top Companies
The Montelukast Market research report discusses the key drivers influencing global growth, opportunities, current challenges and the risks faced by key players and the market as a whole Montelukast Market competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. Montelukast Market is envisaged to record an expansion at
Montelukast Market global outlook and forecast 2021 -2027
The Global Montelukast Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Montelukast makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise spins around the most
Global Montelukast Intermediate Market Growth 2019-2024
LP INFORMATION offers a latest published report on Montelukast Intermediate Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Montelukast Intermediate market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Global Montelukast Sodium Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on Montelukast Sodium Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/583627/global-montelukast-sodium-market-insights   Montelukast sodium is a hygroscopic, optically active,
Global Montelukast Sodium Market Professional Survey Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Global Montelukast Sodium Market Professional Survey Report 2017" Description This report studies Montelukast Sodium in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Morepen